TXG Operating Cash Flow Growth
10X Genomics Inc Class A · Operating Cash Flow Growth
TXG Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported89.82%period ending
TXG TTM Cash from Operations YoY % (145.32% → 89.82%)
Year-over-year change
High-resolution chart · PNG
TXG operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 89.8151% | |
| 125.2714% | |
| 1,941.5666% | |
| 126.002% | |
| 961.119% | |
| 311.7401% | |
| 143.8508% | |
| 243.8381% | |
| 32.3442% | |
| -58.2905% | |
| 54.7789% | |
| 34.4186% | |
| 80.2461% | |
| 55.5588% | |
| -57.2358% | |
| 73.6109% | |
| 68.8509% | |
| 82.638% | |
| 90.1913% | |
| -94.2078% | |
| -1,618.4947% | |
| -1,065.1344% | |
| -729.272% | |
| -251.1746% | |
| 74.5968% | |
| 139.8979% | |
| 145.318% |